Skip to content

Autophagy in Systemic Lupus Erythematosus

Autophagy Genes and Interleukin-10 in Systemic Lupus Erythematosus Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03583853
Enrollment
100
Registered
2018-07-12
Start date
2019-07-01
Completion date
2020-12-01
Last updated
2018-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic Lupus Erythematosus

Brief summary

Systemic lupus erythematosus is systemic autoimmune disease characterized by a wide range of clinical manifestations, from skin and mucosal lesions to severe injuries in the central nervous system, kidneys and other organs. The presence of high titres of autoantibodies against nuclear components, immune complexes deposition, complement deficiency and lymphocytes infiltration in affected tissues, which causes tissue and organ damage are the main characteristics of the disease. Nowadays, many studies elucidate the essential role of autophagy in the occurrence, development and severity of systemic lupus erythematosus.

Detailed description

Autophagy is a highly conserved lysosome-mediated catabolic process. It can remove unwanted cytoplasmic components, such as long-lived and/or misfolded proteins, damaged organelles, playing an important role in maintaining cellular homeostasis and cell survival in stress conditions, such as nutrient deprivation and hypoxia. Recently, Autophagy is implicated in nearly all steps of both innate and adaptive immune responses, including neutrophil extracellular trap and inflammasome formation, pathogen recognition, lymphocyte and monocyte development and function, antigen processing and presentation, type I interferon production and inflammatory regulation, thus playing an important part in maintaining the balance of immune system. Autophagy is divided into three major types: macroautophagy, microautophagy, and chaperone-mediated autophagy, with macroautophagy being the most investigated and understood. Disturbances in autophagy have been implicated in chronic inflammatory diseases and several autoimmune diseases, including Systemic lupus erythematosus, multiple sclerosis, Crohn's disease and rheumatoid arthritis. Several regulatory factors that may play key roles in autophagy processes have been discovered in recent years, such as beclin1, which is the key regulatory factor in the autophagy startup process, microtubule-associated protein-light chain 3, autophagy-related gene 5, which are components of autophagosomes.

Interventions

real time PCR will be used for determination of expression of autophagy genes

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* patients who fulfilled at least four criteria of systemic lupus erythematosus according to American College of Rheumatology

Exclusion criteria

* Pregnancy or lactation. * coexistence of other autoimmune diseases.

Design outcomes

Primary

MeasureTime frameDescription
Change in the expression of autophagy genes in systemic lupus erythematosus patients group and control groupBaseline and 6 monthsthe expression of autophagy genes will be measured by real time polymerase chain reaction

Contacts

Primary ContactMohamed Ali el-feky, prof
mohelfeky@hotmail.com00201223971310
Backup ContactMohamed Saad Badary, prof
Dtn_diatechnology@yahoo.com00201000103328

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026